Albany, NY -- (SBWIRE) -- 03/31/2020 -- Hallux Valgus Market Insights, Epidemiology and Market Forecast-2030

DelveInsight launched a new report on Hallux Valgus Market Insights, Epidemiology and Market Forecast-2030

Some of the key facts of the report
1. The overall prevalence of definite radiographic Hallux Valgus was 29.8%.
2. Hallux valgus appears in at least 2% of children those who are aged 9 to 10 years, and almost half of adults, with a higher prevalence in women.
3. The estimates of Hallux Valgus prevalence were 23% in adults aged 18-65 years and 35.7% in older adults aged over 65 years.

Key benefits of the report
1. Hallux Valgus market report covers a descriptive overview and comprehensive insight of the Hallux Valgus epidemiology and Hallux Valgus market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Hallux Valgus market report provides insights on the current and emerging therapies.
3. Hallux Valgus market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Hallux Valgus market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Hallux Valgus market.

Request for sample pages

"Hallux Valgus more commonly affects females than males."

Currently, Hallux Valgus treatment paradigm is still under clinical trials phase, and there are no approved therapies for the indication. However, various other Hallux Valgus treatment options are available that includes non-surgical treatments, surgical treatments management by physiotherapy. There are many operative techniques for hallux valgus correction. The decision on which surgical technique is used depends on the degree of deformity, the extent of degenerative changes of the first metatarsophalangeal joint and the shape and size of the metatarsal bone and phalangeal deviation. Recently, minimally invasive percutaneous techniques have gained importance and are currently being evaluated more scientifically.

The only available Hallux Valgus treatment options include non-surgical treatments, surgical treatments, management by physiotherapy and several other approaches to relieve the Hallux Valgus symptoms.

The non-surgical treatment of hallux valgus deformity can relieve the symptoms but cannot correct the deformity completely. Non-surgical care should especially be considered in patients with general hypermobility, ligamentous laxity or neuromuscular disorders because of the high recurrence rate. Footwear modification such as accommodating shoes with a wide toe-box, padding over the medial eminence, adjustments to the shoe, night splints or physical therapy and insoles majorly forms the non-operative treatment alternatives.

Various types of surgical treatment techniques can be followed depending upon the extent of the condition for the correction of hallux valgus. The surgical techniques involve the physician that recommend modified McBride procedure, Distal metatarsal osteotomy, Scarf osteotomy, Akin osteotomy, Corrective TMT arthrodesis, MTP joint arthrodesis, MTP joint arthroplasty and others.

The launch of the emerging therapies is expected to significantly impact Hallux Valgus treatment scenario in the upcoming years:-
Drugs covered
1. Dysport
And many others

The key players in Hallux Valgus market are:
1. Ipsen
And many others

Table of contents
1. Report Introduction

2. Hallux Valgus Market Overview at a Glance

3. Hallux Valgus Disease Background and Overview

4. Hallux Valgus Epidemiology and Patient Population (7MM)

5. Hallux Valgus Country- Wise Epidemiology

5.1. United States

5.2. EU5

5.3. Germany

5.4. France

5.5. Italy

5.6. Spain

5.7. United Kingdom

5.8. Japan

6. Hallux Valgus Treatments & Medical Practices

7. Hallux Valgus Emerging Therapies

7.1. Key Cross Competition

7.2. Dysport: Ipsen

8. Hallux Valgus Market Size

9. 7MM: Country-Wise Market Analysis

9.1. United States Market Size

9.2. Germany Market Size

9.3. France Market Size

9.4. United Kingdom Market Size

9.5. Spain Market Size

9.6. Italy Market Size

9.7. Japan Market Size

10. Market Drivers

11. Market Barriers

12. Hallux Valgus Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

15. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
info@delveinsight.com
+919650213330
SOURCE DelveInsight